Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04465968

Efficacy and Safety of CRT, Durvalumab and Surgery for SST — DEEP_OCEAN  

Non Small Cell Lung Cancer Stage III Clinical Trial

Official title:
Efficacy and Safety of Durvalumab Before and After Operation or Durvalumab as Maintenance Therapy After Chemoradiotherapy Against Superior Sulcus Non-small Cell Lung Cancer

Clinical Trial Summary

The safety and efficacy of multimodality treatment of pre- and post-operative durvalumab therapy after pre-operative chemoradiotherapy for resectable superior sulcus tumor (SST) and durvalumab maintenance therapy after chemoradiotherapy for unresectable SST

Clinical Trial Description

To evaluate the safety and efficacy of multimodality treatment of pre- and post-operative durvalumab therapy after pre-operative chemoradiotherapy for resectable superior sulcus tumor (SST) and durvalumab maintenance therapy after chemoradiotherapy for unresectable SST ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04465968
Study type Interventional
Source National Cancer Center Hospital East
Contact Masahiro Tsuboi, MD
Phone +81-4-7133-1111
Email mtsuboi@east.ncc.go.jp
Status Not yet recruiting
Phase Phase 3
Start date September 1, 2020
Completion date August 31, 2030
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02247713 - An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries N/A
Recruiting NCT04711330 - Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy
Completed NCT03845270 - Her2-positive Lung Cancer Treated With Dedicated Drug Phase 2
Active, not recruiting NCT04392505 - Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study Phase 2
Completed NCT04577638 - Accelerated Radio-Immunotherapy for Lung Cancer Phase 2
Recruiting NCT05382052 - Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
Terminated NCT04289259 - Tumor Mutational Burden in Lung Cancer Patients
Recruiting NCT04672759 - A Real-world Study of Durvalumab for Lung Cancer in China
Completed NCT03569072 - High Intensity Functional Image Guided Vmat Lung Evasion N/A
Recruiting NCT02622581 - Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Completed NCT03055715 - Prognostic Evaluation of Tumor Volume and Its Changes in Radical Radiotherapy of Advanced NSCLC